We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Warns Boston Scientific That Corrective Action Plans Insufficient
FDA Warns Boston Scientific That Corrective Action Plans Insufficient
February 2, 2006
The FDA slammed Boston Scientific with a warning letter last week charging that the company’s quality management practices are insufficient, with “serious regulatory problems” found at numerous facilities.